SOURCE: Market Pulse

November 05, 2009 08:30 ET

Market Pulse Breaking News Alert for Thursday, November 5, 2009: ARYC -- Arrayit Corporation to Diagnose Early Stage Cancers and Monitor Effectiveness of Treatments!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse

ATLANTA, GA--(Marketwire - November 5, 2009) - Market Pulse News Alert for this AM, Stocks to Watch are: Arrayit Corporation (OTCBB: ARYC), Merck & Co. Inc. (NYSE: MRK), ON Semiconductor Corp. (NASDAQ: ONNN) and American Lithium Minerals Inc. (OTCBB: AMLM).

Investors need to be watching Arrayit Corporation (OTCBB: ARYC) this AM! Arrayit Corporation is engaged in the development, manufacture, and marketing of life science technologies and integrated systems for the analysis of genetic variation, biological function, and diagnostics. Arrayit offers a product line of approximately 650 tools to 2,500 laboratories worldwide. The company's products include microarrayers, microarray scanners, DNA and protein microarrays, microarray printing, microarray substrates and slides, microarray instruments, amplification and labeling, purification kits, microarray hardware, buffers and solutions, microarray cleanrooms, books and software, CGH microarrays, and microarray platforms. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. The company is also involved in the import, export, and distribution of industrial and food grade chemicals for plastics, fertilizers, and green energy applications. It has research collaboration with The Parkinson's Institute of Sunnyvale to discover biomarkers for Parkinson's disease. ARYC recently announced that it is developing a microarray-based diagnostic test to detect the H1N1 swine flu virus. The 2009 swine flu outbreak has raised concerns at the CDC and the World Health Organization (WHO). The CDC and WHO believe that the current outbreak poses a pandemic risk because the H1N1 flu virus contains genetic elements from both the swine and human influenza viruses, allowing direct human-to-human transmission without the need for agricultural contact. Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries. Arrayit is a leader in the field of molecular diagnostics with patented technology that allows the screening and monitoring of up to 80,000 patient samples on a single microscope slide, rather than testing one patient per slide as is currently practiced. Their corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as their highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for their customers in the research, pharmaceutical, diagnostic, and health care markets! ARYC just had excellent news out in a press release before today's opening bell announcing that they are pleased to join the federal government in their efforts to help control health care cost through early diagnosis of diseases! The company has issued several positive press releases recently and on a technical note, Arrayit Corporation's shares continue to act very well! This could be great news for investors!

Arrayit Corporation (OTCBB: ARYC) is pleased to join the federal government in their efforts to help control health care costs through early diagnosis of diseases.

For more than 150 years, traditional medicine has relied on a 'standards of care' model, which utilizes large cohorts of individuals as the data set and essentially treats every person in an identical manner. While this medical model provides a good paradigm for standard health care practices, it is woefully deficient in that it fails to include genetic and epigenetic differences between people as well as the interplay between our genes and environmental factors including medication, diet and other lifestyle considerations. In a major paradigm shift, personalized medicine is gaining rapid popularity in that it endeavors to provide customized healthcare to individuals inclusive of genetics, epigenetics and the environment, leading to early stage diagnosis of diseases that have exacted a heavy cost in quality and length of life and dollars spent in late stage treatment.

Personalized medicine is a vastly superior advance in health care if it can be delivered at a rate equivalent to or less than the current standards of care model. As a next generation healthcare company, Arrayit Corporation is capable of delivering personalized medical information to the public at a fraction of current costs, owing to the company's unique ability to miniaturize, automate and massively parallelize genomic and proteomic tests. In simple terms, these molecular diagnostic tests, requiring only a blood sample, will be more accurate and less personally invasive than many traditional cancer screening methods. Arrayit's patented microarray manufacturing technology and Variation Identification Platform (VIP) procedures, deployed in clinical laboratories and reference centers, are capable of testing entire population groups. Arrayit personalized medical tests for pre-symptomatic ovarian cancer detection, H1N1 screening, and Parkinson's Disease diagnostics represent only a few of the collaborative milestones soon to be announced.

About Arrayit Corporation

Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. It now offers over 650 products to a customer base, including most every major university, pharmaceutical and biotech company, major agricultural and chemical company, government agency, national research foundation and many private sector enterprises. Please visit www.arrayit.com for more information.

Stocks in the news and acting well as of late include: Merck & Co. Inc. (NYSE: MRK), ON Semiconductor Corp. (NASDAQ: ONNN) and American Lithium Minerals Inc. (OTCBB: AMLM).

Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated, in connection with its profile of Arrayit Corporation, one hundred thousand shares of Arrayit Corporation's common stock by a third party shareholder. Additionally, MP bought for its own account in the open market, forty thousand shares of Arrayit Corporation's shares for a total purchase price of twenty three thousand eight hundred twenty dollars. To date, MP has sold forty thousand shares of stock in Arrayit Corporation for proceeds totaling twenty six thousand one hundred seventeen dollars. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market-Pulse.com and Market Pulse Breaking News Alert are owned by Market Pulse LLC.

Contact Information